Bullboard - Stock Discussion Forum WPD Pharmaceuticals Inc C.WBIO

Alternate Symbol(s): WPDPF

Industrials Technology

WPD Pharmaceuticals Inc. is a Canada-based clinical-stage pharmaceutical company, with a focus on glioblastoma cancer (GBM) and other brain tumor programs. The Company is a biotechnology research and development company with a focus on oncology, namely research and development of medicinal products involving biological compounds and small molecules. It has four novel drug candidates with one in... see more

Add To Watchlist

CSE:WBIO - Post Discussion

WPD Pharmaceuticals Inc > WPD receives approval for Annamycin dose escalation

View:

Post by etcetera on Apr 29, 2020 9:50am

WPD receives approval for Annamycin dose escalation

2020-04-29 07:33 ET - News Release

Mr. Mariusz Olejniczak reports

WPD PHARMACEUTICAL'S ANNAMYCIN DRUG APPROVED FOR ACCELERATED EUROPEAN CLINICAL TRIAL

Through its licence partner, Moleculin Biotech Inc., WPD Pharmaceuticals Inc. has been authorized by the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products, known as URPL, to accelerate the phase 1 dose escalation portion of its clinical trial of Annamycin for the treatment of acute myeloid leukemia (AML).

https://www.stockwatch.com/News/Item?bid=Z-C%3aWBIO-2897150&symbol=WBIO&region=C

173